Bausch Health Cos., Inc.
(Toronto Stock Exchange : BHC)

( )
BHC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -0.07%30.2414.1%$177.94m
HZNPHorizon Therapeutics Plc 0.00%91.455.5%$174.64m
GWPHGW Pharmaceuticals Plc 0.00%218.366.1%$132.57m
CTLTCatalent, Inc. 0.06%109.982.1%$128.58m
BHCBausch Health Cos., Inc. -0.07%30.240.0%$123.31m
ICLRICON plc 0.00%196.434.2%$121.81m
UTHRUnited Therapeutics Corp. 0.60%204.0014.1%$99.57m
JAZZJazz Pharmaceuticals Plc 0.00%166.372.3%$88.00m
SAVACassava Sciences, Inc. 0.08%35.700.0%$69.85m
ARGXargenx SE 0.81%275.000.0%$51.37m
SAGESAGE Therapeutics, Inc. 0.00%75.677.6%$37.98m
PRGOPerrigo Co. Plc 0.07%40.416.9%$37.14m
AMRNAmarin Corp. Plc 0.98%5.161.5%$29.09m
PCRXPacira Biosciences, Inc. 0.00%69.439.9%$26.96m
ICPTIntercept Pharmaceuticals, Inc. 0.00%21.4116.8%$21.61m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.